Jan 8 (Reuters) - Diamyd Medical Ab:
* THE DIABETES VACCINE DIAMYD® SHOWS CONTINUED POSITIVE CLINICAL COURSE AFTER 30 MONTHS
* ‍DATA INDICATE THAT DISEASE PROGRESSION IS STILL POSITIVE AT 30 MONTHS FOR THESE FIRST FOUR PATIENTS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 